Though the AD research field has shifted in recent years from the amyloid cascade hypothesis to focusing on τ, inflammation, metabolism, and hyperactivity, the impact of APOE4 on Aβ pathology still deserves attention as a potential target for disease-modifying treatment. The gene discussed is TBXT; the disease is Alzheimer disease.